Founded in 2018 and based in Greenwich, Connecticut, Soleus Capital seeks to generate high returns through investing in biotechnology and medical technology companies. The firm's investment strategy is focused on complex and niche opportunities in both the public and private sectors, with a particular emphasis on catalyst-driven investing. Through its idiosyncratic approach, Soleus Capital aims to achieve superior risk-adjusted returns for its investors.